Detalles de la búsqueda
1.
Low-dose versus standard-dose olanzapine with triple antiemetic therapy for prevention of highly emetogenic chemotherapy-induced nausea and vomiting in patients with solid tumours: a single-centre, open-label, non-inferiority, randomised, controlled, phase 3 trial.
Lancet Oncol
; 25(2): 246-254, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38224701
2.
Modified FOLFIRINOX compared to Gemcitabine & nab-Paclitaxel in advanced pancreatic ductal adenocarcinoma - results of a match-pair analysis.
Indian J Med Res
; 157(1): 57-65, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37040228
3.
Phase I Study Evaluating Dose De-escalation of Sorafenib with Metformin and Atorvastatin in Hepatocellular Carcinoma (SMASH).
Oncologist
; 27(3): 165-e222, 2022 03 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35274724
4.
Capecitabine-Temozolomide in Advanced Grade 2 and Grade 3 Neuroendocrine Neoplasms: Benefits of Chemotherapy in Neuroendocrine Neoplasms with Significant 18FDG Uptake.
Neuroendocrinology
; 111(10): 998-1004, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33017827
5.
Adolescent-adult nonmetastatic Ewing sarcoma-Experience from a large developing country.
Pediatr Blood Cancer
; 68(9): e29081, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33991401
6.
A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancer.
Cancer
; 125(18): 3184-3197, 2019 09 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31150120
7.
Thromboembolic events in brain tumour patients on bevacizumab.
Acta Oncol
; 59(12): 1543-1546, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32897111
8.
Modified FOLFIRINOX (mFOLFIRINOX) as neoadjuvant therapy and 'salvage' in patients with high risk locally advanced rectal cancers - tolerance and early outcomes.
J Cancer Res Ther
; 20(1): 199-203, 2024 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38554321
9.
Trastuzumab Plus Gemcitabine-Cisplatin for Treatment-Naïve Human Epidermal Growth Factor Receptor 2-Positive Biliary Tract Adenocarcinoma: A Multicenter, Open-Label, Phase II Study (TAB).
J Clin Oncol
; 42(7): 800-807, 2024 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37944079
10.
Evaluation of Metronomic Therapy as a Low-Cost, Sustainable, Standard-of-Care Option in Desmoid Fibromatosis: Real-World Data From a Tertiary Care Center in India.
JCO Glob Oncol
; 10: e2300308, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38723218
11.
Phase 3 RCT comparing docetaxel-platinum with docetaxel-platinum-5FU as neoadjuvant chemotherapy in borderline resectable oral cancer.
Eur J Cancer
; 200: 113560, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38306841
12.
Perioperative Modified FLOT Versus EOX in Locally Advanced Resectable Gastric and Gastro-Oesophageal Junction Adenocarcinoma: Results of a Matched-Pair Analysis.
J Gastrointest Cancer
; 54(3): 820-828, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-36242748
13.
Gemcitabine, Cisplatin, and Nab-Paclitaxel as a First-Line Therapy for Advanced Biliary Tract Cancers.
J Gastrointest Cancer
; 2023 Jun 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-37368175
14.
Survival of Trial-Like and Non-Trial-Like Patients With Immunotherapy in Advanced Hepatocellular Carcinoma in Real World: A Collaborative Multicenter Indian Study (IMHEP).
JCO Glob Oncol
; 9: e2300215, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-38033275
15.
Practice Patterns and Survival in Patients with Resected Pancreatic Ductal Adenocarcinomas (PDAC) - Results from the Multicentre Indian Pancreatic & Periampullary Adenocarcinoma Project (MIPPAP) Study.
J Gastrointest Cancer
; 54(4): 1338-1346, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37273074
16.
Systemic therapy in pancreatic ductal adenocarcinomas (PDACs)-basis and current status.
Ecancermedicalscience
; 16: 1367, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35685956
17.
An Analysis of Tolerance and Early Survival Outcomes with Perioperative Modified FLOT in Gastric Cancers.
South Asian J Cancer
; 11(2): 112-117, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36466971
18.
Outcomes of Ewing sarcoma in adults over 40 years of age from a low-middle income country.
Ecancermedicalscience
; 16: 1361, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35685954
19.
A pro-oxidant combination of resveratrol and copper reduces chemotherapy-related non-haematological toxicities in advanced gastric cancer: results of a prospective open label phase II single-arm study (RESCU III study).
Med Oncol
; 40(1): 17, 2022 Nov 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-36372825
20.
Neoadjuvant chemotherapy in technically unresectable head and neck cancers: a retrospective audit.
Ecancermedicalscience
; 16: 1460, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36819802